“I Feel Validated”: Participation in a Medical Cannabis Program in the Context of Legalized Recreational Use

AuthorSaranya Khurana,Ekaterina V. Fedorova,Harjot Kaur,Allison Mitchell,Sari Kosdon,Janna Ataiants,Bridgid Conn,Carolyn F. Wong,Stephen E. Lankenau
DOIhttp://doi.org/10.1177/00220426221097924
Published date01 October 2022
Date01 October 2022
Subject MatterArticles
Article
Journal of Drug Issues
2022, Vol. 52(4) 601615
© The Author(s) 2022
Article reuse guidelines:
sagepub.com/journals-permissions
DOI: 10.1177/00220426221097924
journals.sagepub.com/home/jod
I Feel Validated: Participation
in a Medical Cannabis Program
in the Context of Legalized
Recreational Use
Saranya Khurana
1,2
, Ekaterina V. Fedorova
1
, Harjot Kaur
1
,
Allison Mitchell
1
, Sari Kosdon
3
, Janna Ataiants
1
, Bridgid Conn
3,4
,
Carolyn F. Wong
3,4,5
and Stephen E. Lankenau
1
Abstract
We examined the effects of Californias 2016 law legalizing cannabis for recreational use among
young adult medical cannabis patients (MCP) and non-patient users (NPU). Three groups of young
adult cannabis users (n= 30) were qualitatively interviewed in Los Angeles between 2020-21:
current MCP (n= 3), who always had a medical cannabis recommendation, NPU (n= 6), who
never had a recommendation, and MCP-to-NPU (n= 21), who had a recommendation in the past.
MCP remained MCP due to greater acceptance of cannabis and lower prices afforded to MCP.
MCP-to-NPU and NPU remained NPU due to increased acceptance of cannabis use within their
community, greater legal security, and no compelling need for a medical cannabis recommen-
dation. Price increases drove many to purchasing cannabis from unregulated black-market dis-
pensaries. The legalization of cannabis for recreational use led to decisions to transition out of
MCP status, destigmatization of cannabis use, increased prices of cannabis, and increased sourcing
of cannabis from the black-market.
Keywords
cannabis, medical cannabis, qualitative research, legalization, young adults
1
Drexel University, Dornsife School of Public Health, Department of Community Health and Prevention, Philadelphia, PA,
USA
2
Drexel University, College of Medicine, Department of Psychiatry, Philadelphia, PA, USA
3
Childrens Hospital Los Angeles, Division of Adolescent Medicine, Los Angeles, CA, USA
4
University of Southern California, Keck School of Medicine, Department of Pediatrics, Los Angeles, CA, USA
5
Childrens Hospital Los Angeles, Division of Research on Children, Youth, & Families, Los Angeles, CA, USA
Corresponding Author:
Saranya Khurana, Drexel University, Dornsife School of Public Health, Department of Community Health and
Prevention, 3215 Market Street, Philadelphia, PA 19104, USA.
Email: ssk64@drexel.edu

To continue reading

Request your trial

VLEX uses login cookies to provide you with a better browsing experience. If you click on 'Accept' or continue browsing this site we consider that you accept our cookie policy. ACCEPT